Free Trial

PROCEPT BioRobotics (PRCT) Competitors

PROCEPT BioRobotics logo
$57.04 -0.97 (-1.67%)
Closing price 04:00 PM Eastern
Extended Trading
$55.87 -1.17 (-2.05%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRCT vs. PEN, STVN, GKOS, BLCO, NARI, IRTC, SLNO, TMDX, INSP, and NVST

Should you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), and Envista (NVST). These companies are all part of the "medical equipment" industry.

PROCEPT BioRobotics vs. Its Competitors

PROCEPT BioRobotics (NASDAQ:PRCT) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, PROCEPT BioRobotics had 4 more articles in the media than Penumbra. MarketBeat recorded 12 mentions for PROCEPT BioRobotics and 8 mentions for Penumbra. Penumbra's average media sentiment score of 0.58 beat PROCEPT BioRobotics' score of 0.34 indicating that Penumbra is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PROCEPT BioRobotics
0 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Penumbra
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PROCEPT BioRobotics has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.

PROCEPT BioRobotics presently has a consensus price target of $84.13, suggesting a potential upside of 47.48%. Penumbra has a consensus price target of $305.07, suggesting a potential upside of 30.24%. Given PROCEPT BioRobotics' higher possible upside, equities research analysts clearly believe PROCEPT BioRobotics is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PROCEPT BioRobotics
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88

Penumbra has a net margin of 3.41% compared to PROCEPT BioRobotics' net margin of -36.20%. Penumbra's return on equity of 11.14% beat PROCEPT BioRobotics' return on equity.

Company Net Margins Return on Equity Return on Assets
PROCEPT BioRobotics-36.20% -28.09% -20.02%
Penumbra 3.41%11.14%8.40%

Penumbra has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PROCEPT BioRobotics$224.50M14.06-$91.41M-$1.70-33.55
Penumbra$1.19B7.59$14.01M$1.06220.98

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by insiders. Comparatively, 5.0% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Penumbra beats PROCEPT BioRobotics on 11 of the 17 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRCT vs. The Competition

MetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.16B$6.67B$5.57B$9.31B
Dividend YieldN/A1.20%4.23%4.03%
P/E Ratio-33.5525.4928.6119.73
Price / Sales14.0687.71411.31174.27
Price / CashN/A20.3636.0257.96
Price / Book7.404.668.235.67
Net Income-$91.41M$174.76M$3.23B$257.79M
7 Day Performance-2.43%-1.13%-0.01%0.52%
1 Month Performance-5.56%1.22%5.60%8.84%
1 Year Performance-18.23%2.58%26.54%14.18%

PROCEPT BioRobotics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRCT
PROCEPT BioRobotics
2.479 of 5 stars
$57.04
-1.7%
$84.13
+47.5%
-13.2%$3.16B$224.50M-33.55430News Coverage
Analyst Forecast
Analyst Revision
PEN
Penumbra
4.7335 of 5 stars
$248.05
-1.2%
$302.40
+21.9%
+23.4%$9.61B$1.19B234.014,500
STVN
Stevanato Group
N/A€24.23
-1.5%
N/A+21.0%€7.34B€1.19B47.515,521Positive News
GKOS
Glaukos
4.3346 of 5 stars
$101.69
-1.7%
$134.67
+32.4%
-20.2%$5.81B$383.48M-42.91780Analyst Forecast
BLCO
Bausch + Lomb
3.0202 of 5 stars
$13.83
-0.4%
$15.54
+12.4%
-13.4%$4.89B$4.83B-13.4313,500
NARI
Inari Medical
0.2605 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.0172 of 5 stars
$139.22
-2.3%
$138.60
-0.4%
+35.8%$4.44B$591.84M-44.342,000Analyst Forecast
SLNO
Soleno Therapeutics
4.5814 of 5 stars
$85.27
-1.6%
$107.10
+25.6%
+66.5%$4.30BN/A-18.4630
TMDX
TransMedics Group
2.2586 of 5 stars
$125.17
-3.1%
$127.33
+1.7%
-19.9%$4.23B$441.54M92.04210Positive News
Analyst Forecast
INSP
Inspire Medical Systems
4.8607 of 5 stars
$127.11
-1.1%
$211.91
+66.7%
-7.8%$3.75B$802.80M58.581,246Positive News
Analyst Forecast
NVST
Envista
3.3623 of 5 stars
$19.66
-3.6%
$20.23
+2.9%
+24.2%$3.33B$2.51B-3.0112,300Analyst Revision

Related Companies and Tools


This page (NASDAQ:PRCT) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners